img

Global TCR Based Therapy Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global TCR Based Therapy Market Insights, Forecast to 2034

Market Analysis and InsightsGlobal TCR Based Therapy Market
Global TCR Based Therapy market is expected to reach to US$ 47 million in 2023, with a positive growth of %, compared with US$ 45 million in 2022. Backed with the increasing demand from downstream industries, TCR Based Therapy industry is evaluated to reach US$ 63 million in 2033. The CAGR will be 4.8% during 2023 to 2033.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers
This report presents an overview of global TCR Based Therapy market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global TCR Based Therapy market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


Adaptimmune Therapeutics
Alaunos Therapeutics
Bristol Myers Squibb
Cellular Biomedicine
Gilead Biosciences
GlaxoSmithKline
Immatics
Immunocore
Lion TCR
Takara Bio
Zelluna Immunotherapy
Segment by Type
Transduction of Chimeric Antigen Receptor
Transduction of TCR α/β Heterodimer

Segment by Application


Hospitals
Clinics & Ambulatory Centers
Cancer Research Institutes
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, TCR Based Therapy introduction, etc. TCR Based Therapy Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of TCR Based Therapy
Chapter 13Methodology and Data Sources adopted by MRAResearch

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global TCR Based Therapy Market Size Growth Rate by Type, 2018 VS 2022 VS 2033
1.2.2 Transduction of Chimeric Antigen Receptor
1.2.3 Transduction of TCR α/β Heterodimer
1.3 Market by Application
1.3.1 Global TCR Based Therapy Market Size Growth Rate by Application, 2018 VS 2022 VS 2033
1.3.2 Hospitals
1.3.3 Clinics & Ambulatory Centers
1.3.4 Cancer Research Institutes
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global TCR Based Therapy Market Perspective (2018-2033)
2.2 Global TCR Based Therapy Growth Trends by Region
2.2.1 TCR Based Therapy Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 TCR Based Therapy Historic Market Size by Region (2018-2023)
2.2.3 TCR Based Therapy Forecasted Market Size by Region (2024-2033)
2.3 TCR Based Therapy Market Dynamics
2.3.1 TCR Based Therapy Industry Trends
2.3.2 TCR Based Therapy Market Drivers
2.3.3 TCR Based Therapy Market Challenges
2.3.4 TCR Based Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue TCR Based Therapy by Players
3.1.1 Global TCR Based Therapy Revenue by Players (2018-2023)
3.1.2 Global TCR Based Therapy Revenue Market Share by Players (2018-2023)
3.2 Global TCR Based Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of TCR Based Therapy, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global TCR Based Therapy Market Concentration Ratio
3.4.1 Global TCR Based Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by TCR Based Therapy Revenue in 2022
3.5 Global Key Players of TCR Based Therapy Head office and Area Served
3.6 Global Key Players of TCR Based Therapy, Product and Application
3.7 Global Key Players of TCR Based Therapy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 TCR Based Therapy Breakdown Data by Type
4.1 Global TCR Based Therapy Historic Market Size by Type (2018-2023)
4.2 Global TCR Based Therapy Forecasted Market Size by Type (2024-2033)
5 TCR Based Therapy Breakdown Data by Application
5.1 Global TCR Based Therapy Historic Market Size by Application (2018-2023)
5.2 Global TCR Based Therapy Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America TCR Based Therapy Market Size (2018-2033)
6.2 North America TCR Based Therapy Market Size by Type
6.2.1 North America TCR Based Therapy Market Size by Type (2018-2023)
6.2.2 North America TCR Based Therapy Market Size by Type (2024-2033)
6.2.3 North America TCR Based Therapy Market Share by Type (2018-2033)
6.3 North America TCR Based Therapy Market Size by Application
6.3.1 North America TCR Based Therapy Market Size by Application (2018-2023)
6.3.2 North America TCR Based Therapy Market Size by Application (2024-2033)
6.3.3 North America TCR Based Therapy Market Share by Application (2018-2033)
6.4 North America TCR Based Therapy Market Size by Country
6.4.1 North America TCR Based Therapy Market Size by Country: 2018 VS 2022 VS 2033
6.4.2 North America TCR Based Therapy Market Size by Country (2018-2023)
6.4.3 North America TCR Based Therapy Market Size by Country (2024-2033)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe TCR Based Therapy Market Size (2018-2033)
7.2 Europe TCR Based Therapy Market Size by Type
7.2.1 Europe TCR Based Therapy Market Size by Type (2018-2023)
7.2.2 Europe TCR Based Therapy Market Size by Type (2024-2033)
7.2.3 Europe TCR Based Therapy Market Share by Type (2018-2033)
7.3 Europe TCR Based Therapy Market Size by Application
7.3.1 Europe TCR Based Therapy Market Size by Application (2018-2023)
7.3.2 Europe TCR Based Therapy Market Size by Application (2024-2033)
7.3.3 Europe TCR Based Therapy Market Share by Application (2018-2033)
7.4 Europe TCR Based Therapy Market Size by Country
7.4.1 Europe TCR Based Therapy Market Size by Country: 2018 VS 2022 VS 2033
7.4.2 Europe TCR Based Therapy Market Size by Country (2018-2023)
7.4.3 Europe TCR Based Therapy Market Size by Country (2024-2033)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China TCR Based Therapy Market Size (2018-2033)
8.2 China TCR Based Therapy Market Size by Type
8.2.1 China TCR Based Therapy Market Size by Type (2018-2023)
8.2.2 China TCR Based Therapy Market Size by Type (2024-2033)
8.2.3 China TCR Based Therapy Market Share by Type (2018-2033)
8.3 China TCR Based Therapy Market Size by Application
8.3.1 China TCR Based Therapy Market Size by Application (2018-2023)
8.3.2 China TCR Based Therapy Market Size by Application (2024-2033)
8.3.3 China TCR Based Therapy Market Share by Application (2018-2033)
9 Asia (excluding China)
9.1 Asia TCR Based Therapy Market Size (2018-2033)
9.2 Asia TCR Based Therapy Market Size by Type
9.2.1 Asia TCR Based Therapy Market Size by Type (2018-2023)
9.2.2 Asia TCR Based Therapy Market Size by Type (2024-2033)
9.2.3 Asia TCR Based Therapy Market Share by Type (2018-2033)
9.3 Asia TCR Based Therapy Market Size by Application
9.3.1 Asia TCR Based Therapy Market Size by Application (2018-2023)
9.3.2 Asia TCR Based Therapy Market Size by Application (2024-2033)
9.3.3 Asia TCR Based Therapy Market Share by Application (2018-2033)
9.4 Asia TCR Based Therapy Market Size by Region
9.4.1 Asia TCR Based Therapy Market Size by Region: 2018 VS 2022 VS 2033
9.4.2 Asia TCR Based Therapy Market Size by Region (2018-2023)
9.4.3 Asia TCR Based Therapy Market Size by Region (2024-2033)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America TCR Based Therapy Market Size (2018-2033)
10.2 Middle East, Africa, and Latin America TCR Based Therapy Market Size by Type
10.2.1 Middle East, Africa, and Latin America TCR Based Therapy Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America TCR Based Therapy Market Size by Type (2024-2033)
10.2.3 Middle East, Africa, and Latin America TCR Based Therapy Market Share by Type (2018-2033)
10.3 Middle East, Africa, and Latin America TCR Based Therapy Market Size by Application
10.3.1 Middle East, Africa, and Latin America TCR Based Therapy Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America TCR Based Therapy Market Size by Application (2024-2033)
10.3.3 Middle East, Africa, and Latin America TCR Based Therapy Market Share by Application (2018-2033)
10.4 Middle East, Africa, and Latin America TCR Based Therapy Market Size by Country
10.4.1 Middle East, Africa, and Latin America TCR Based Therapy Market Size by Country: 2018 VS 2022 VS 2033
10.4.2 Middle East, Africa, and Latin America TCR Based Therapy Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America TCR Based Therapy Market Size by Country (2024-2033)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Adaptimmune Therapeutics
11.1.1 Adaptimmune Therapeutics Company Details
11.1.2 Adaptimmune Therapeutics Business Overview
11.1.3 Adaptimmune Therapeutics TCR Based Therapy Introduction
11.1.4 Adaptimmune Therapeutics Revenue in TCR Based Therapy Business (2018-2023)
11.1.5 Adaptimmune Therapeutics Recent Developments
11.2 Alaunos Therapeutics
11.2.1 Alaunos Therapeutics Company Details
11.2.2 Alaunos Therapeutics Business Overview
11.2.3 Alaunos Therapeutics TCR Based Therapy Introduction
11.2.4 Alaunos Therapeutics Revenue in TCR Based Therapy Business (2018-2023)
11.2.5 Alaunos Therapeutics Recent Developments
11.3 Bristol Myers Squibb
11.3.1 Bristol Myers Squibb Company Details
11.3.2 Bristol Myers Squibb Business Overview
11.3.3 Bristol Myers Squibb TCR Based Therapy Introduction
11.3.4 Bristol Myers Squibb Revenue in TCR Based Therapy Business (2018-2023)
11.3.5 Bristol Myers Squibb Recent Developments
11.4 Cellular Biomedicine
11.4.1 Cellular Biomedicine Company Details
11.4.2 Cellular Biomedicine Business Overview
11.4.3 Cellular Biomedicine TCR Based Therapy Introduction
11.4.4 Cellular Biomedicine Revenue in TCR Based Therapy Business (2018-2023)
11.4.5 Cellular Biomedicine Recent Developments
11.5 Gilead Biosciences
11.5.1 Gilead Biosciences Company Details
11.5.2 Gilead Biosciences Business Overview
11.5.3 Gilead Biosciences TCR Based Therapy Introduction
11.5.4 Gilead Biosciences Revenue in TCR Based Therapy Business (2018-2023)
11.5.5 Gilead Biosciences Recent Developments
11.6 GlaxoSmithKline
11.6.1 GlaxoSmithKline Company Details
11.6.2 GlaxoSmithKline Business Overview
11.6.3 GlaxoSmithKline TCR Based Therapy Introduction
11.6.4 GlaxoSmithKline Revenue in TCR Based Therapy Business (2018-2023)
11.6.5 GlaxoSmithKline Recent Developments
11.7 Immatics
11.7.1 Immatics Company Details
11.7.2 Immatics Business Overview
11.7.3 Immatics TCR Based Therapy Introduction
11.7.4 Immatics Revenue in TCR Based Therapy Business (2018-2023)
11.7.5 Immatics Recent Developments
11.8 Immunocore
11.8.1 Immunocore Company Details
11.8.2 Immunocore Business Overview
11.8.3 Immunocore TCR Based Therapy Introduction
11.8.4 Immunocore Revenue in TCR Based Therapy Business (2018-2023)
11.8.5 Immunocore Recent Developments
11.9 Lion TCR
11.9.1 Lion TCR Company Details
11.9.2 Lion TCR Business Overview
11.9.3 Lion TCR TCR Based Therapy Introduction
11.9.4 Lion TCR Revenue in TCR Based Therapy Business (2018-2023)
11.9.5 Lion TCR Recent Developments
11.10 Takara Bio
11.10.1 Takara Bio Company Details
11.10.2 Takara Bio Business Overview
11.10.3 Takara Bio TCR Based Therapy Introduction
11.10.4 Takara Bio Revenue in TCR Based Therapy Business (2018-2023)
11.10.5 Takara Bio Recent Developments
11.11 Zelluna Immunotherapy
11.11.1 Zelluna Immunotherapy Company Details
11.11.2 Zelluna Immunotherapy Business Overview
11.11.3 Zelluna Immunotherapy TCR Based Therapy Introduction
11.11.4 Zelluna Immunotherapy Revenue in TCR Based Therapy Business (2018-2023)
11.11.5 Zelluna Immunotherapy Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global TCR Based Therapy Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2033
Table 2. Key Players of Transduction of Chimeric Antigen Receptor
Table 3. Key Players of Transduction of TCR α/β Heterodimer
Table 4. Global TCR Based Therapy Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2033
Table 5. Global TCR Based Therapy Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global TCR Based Therapy Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global TCR Based Therapy Market Share by Region (2018-2023)
Table 8. Global TCR Based Therapy Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 9. Global TCR Based Therapy Market Share by Region (2024-2033)
Table 10. TCR Based Therapy Market Trends
Table 11. TCR Based Therapy Market Drivers
Table 12. TCR Based Therapy Market Challenges
Table 13. TCR Based Therapy Market Restraints
Table 14. Global TCR Based Therapy Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global TCR Based Therapy Revenue Share by Players (2018-2023)
Table 16. Global Top TCR Based Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in TCR Based Therapy as of 2022)
Table 17. Global TCR Based Therapy Industry Ranking 2021 VS 2022 VS 2023
Table 18. Global 5 Largest Players Market Share by TCR Based Therapy Revenue (CR5 and HHI) & (2018-2023)
Table 19. Global Key Players of TCR Based Therapy, Headquarters and Area Served
Table 20. Global Key Players of TCR Based Therapy, Product and Application
Table 21. Global Key Players of TCR Based Therapy, Product and Application
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global TCR Based Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global TCR Based Therapy Revenue Market Share by Type (2018-2023)
Table 25. Global TCR Based Therapy Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 26. Global TCR Based Therapy Revenue Market Share by Type (2024-2033)
Table 27. Global TCR Based Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global TCR Based Therapy Revenue Share by Application (2018-2023)
Table 29. Global TCR Based Therapy Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 30. Global TCR Based Therapy Revenue Share by Application (2024-2033)
Table 31. North America TCR Based Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 32. North America TCR Based Therapy Market Size by Type (2024-2033) & (US$ Million)
Table 33. North America TCR Based Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 34. North America TCR Based Therapy Market Size by Application (2024-2033) & (US$ Million)
Table 35. North America TCR Based Therapy Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 36. North America TCR Based Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 37. North America TCR Based Therapy Market Size by Country (2024-2033) & (US$ Million)
Table 38. Europe TCR Based Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 39. Europe TCR Based Therapy Market Size by Type (2024-2033) & (US$ Million)
Table 40. Europe TCR Based Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 41. Europe TCR Based Therapy Market Size by Application (2024-2033) & (US$ Million)
Table 42. Europe TCR Based Therapy Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 43. Europe TCR Based Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 44. Europe TCR Based Therapy Market Size by Country (2024-2033) & (US$ Million)
Table 45. China TCR Based Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 46. China TCR Based Therapy Market Size by Type (2024-2033) & (US$ Million)
Table 47. China TCR Based Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 48. China TCR Based Therapy Market Size by Application (2024-2033) & (US$ Million)
Table 49. Asia TCR Based Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 50. Asia TCR Based Therapy Market Size by Type (2024-2033) & (US$ Million)
Table 51. Asia TCR Based Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 52. Asia TCR Based Therapy Market Size by Application (2024-2033) & (US$ Million)
Table 53. Asia TCR Based Therapy Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 54. Asia TCR Based Therapy Market Size by Region (2018-2023) & (US$ Million)
Table 55. Asia TCR Based Therapy Market Size by Region (2024-2033) & (US$ Million)
Table 56. Middle East, Africa, and Latin America TCR Based Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 57. Middle East, Africa, and Latin America TCR Based Therapy Market Size by Type (2024-2033) & (US$ Million)
Table 58. Middle East, Africa, and Latin America TCR Based Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 59. Middle East, Africa, and Latin America TCR Based Therapy Market Size by Application (2024-2033) & (US$ Million)
Table 60. Middle East, Africa, and Latin America TCR Based Therapy Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 61. Middle East, Africa, and Latin America TCR Based Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 62. Middle East, Africa, and Latin America TCR Based Therapy Market Size by Country (2024-2033) & (US$ Million)
Table 63. Adaptimmune Therapeutics Company Details
Table 64. Adaptimmune Therapeutics Business Overview
Table 65. Adaptimmune Therapeutics TCR Based Therapy Product
Table 66. Adaptimmune Therapeutics Revenue in TCR Based Therapy Business (2018-2023) & (US$ Million)
Table 67. Adaptimmune Therapeutics Recent Developments
Table 68. Alaunos Therapeutics Company Details
Table 69. Alaunos Therapeutics Business Overview
Table 70. Alaunos Therapeutics TCR Based Therapy Product
Table 71. Alaunos Therapeutics Revenue in TCR Based Therapy Business (2018-2023) & (US$ Million)
Table 72. Alaunos Therapeutics Recent Developments
Table 73. Bristol Myers Squibb Company Details
Table 74. Bristol Myers Squibb Business Overview
Table 75. Bristol Myers Squibb TCR Based Therapy Product
Table 76. Bristol Myers Squibb Revenue in TCR Based Therapy Business (2018-2023) & (US$ Million)
Table 77. Bristol Myers Squibb Recent Developments
Table 78. Cellular Biomedicine Company Details
Table 79. Cellular Biomedicine Business Overview
Table 80. Cellular Biomedicine TCR Based Therapy Product
Table 81. Cellular Biomedicine Revenue in TCR Based Therapy Business (2018-2023) & (US$ Million)
Table 82. Cellular Biomedicine Recent Developments
Table 83. Gilead Biosciences Company Details
Table 84. Gilead Biosciences Business Overview
Table 85. Gilead Biosciences TCR Based Therapy Product
Table 86. Gilead Biosciences Revenue in TCR Based Therapy Business (2018-2023) & (US$ Million)
Table 87. Gilead Biosciences Recent Developments
Table 88. GlaxoSmithKline Company Details
Table 89. GlaxoSmithKline Business Overview
Table 90. GlaxoSmithKline TCR Based Therapy Product
Table 91. GlaxoSmithKline Revenue in TCR Based Therapy Business (2018-2023) & (US$ Million)
Table 92. GlaxoSmithKline Recent Developments
Table 93. Immatics Company Details
Table 94. Immatics Business Overview
Table 95. Immatics TCR Based Therapy Product
Table 96. Immatics Revenue in TCR Based Therapy Business (2018-2023) & (US$ Million)
Table 97. Immatics Recent Developments
Table 98. Immunocore Company Details
Table 99. Immunocore Business Overview
Table 100. Immunocore TCR Based Therapy Product
Table 101. Immunocore Revenue in TCR Based Therapy Business (2018-2023) & (US$ Million)
Table 102. Immunocore Recent Developments
Table 103. Lion TCR Company Details
Table 104. Lion TCR Business Overview
Table 105. Lion TCR TCR Based Therapy Product
Table 106. Lion TCR Revenue in TCR Based Therapy Business (2018-2023) & (US$ Million)
Table 107. Lion TCR Recent Developments
Table 108. Takara Bio Company Details
Table 109. Takara Bio Business Overview
Table 110. Takara Bio TCR Based Therapy Product
Table 111. Takara Bio Revenue in TCR Based Therapy Business (2018-2023) & (US$ Million)
Table 112. Takara Bio Recent Developments
Table 113. Zelluna Immunotherapy Company Details
Table 114. Zelluna Immunotherapy Business Overview
Table 115. Zelluna Immunotherapy TCR Based Therapy Product
Table 116. Zelluna Immunotherapy Revenue in TCR Based Therapy Business (2018-2023) & (US$ Million)
Table 117. Zelluna Immunotherapy Recent Developments
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
List of Figures
Figure 1. Global TCR Based Therapy Market Size Growth Rate by Type, 2018 VS 2022 VS 2033 (US$ Million)
Figure 2. Global TCR Based Therapy Market Share by Type: 2022 VS 2033
Figure 3. Transduction of Chimeric Antigen Receptor Features
Figure 4. Transduction of TCR α/β Heterodimer Features
Figure 5. Global TCR Based Therapy Market Size Growth Rate by Application, 2018 VS 2022 VS 2033 (US$ Million)
Figure 6. Global TCR Based Therapy Market Share by Application: 2022 VS 2033
Figure 7. Hospitals Case Studies
Figure 8. Clinics & Ambulatory Centers Case Studies
Figure 9. Cancer Research Institutes Case Studies
Figure 10. Others Case Studies
Figure 11. TCR Based Therapy Report Years Considered
Figure 12. Global TCR Based Therapy Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 13. Global TCR Based Therapy Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 14. Global TCR Based Therapy Market Share by Region: 2022 VS 2033
Figure 15. Global TCR Based Therapy Market Share by Players in 2022
Figure 16. Global Top TCR Based Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in TCR Based Therapy as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by TCR Based Therapy Revenue in 2022
Figure 18. North America TCR Based Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 19. North America TCR Based Therapy Market Share by Type (2018-2033)
Figure 20. North America TCR Based Therapy Market Share by Application (2018-2033)
Figure 21. North America TCR Based Therapy Market Share by Country (2018-2033)
Figure 22. United States TCR Based Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Canada TCR Based Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Europe TCR Based Therapy Market Size YoY (2018-2033) & (US$ Million)
Figure 25. Europe TCR Based Therapy Market Share by Type (2018-2033)
Figure 26. Europe TCR Based Therapy Market Share by Application (2018-2033)
Figure 27. Europe TCR Based Therapy Market Share by Country (2018-2033)
Figure 28. Germany TCR Based Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. France TCR Based Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. U.K. TCR Based Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Italy TCR Based Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Russia TCR Based Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Nordic Countries TCR Based Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. China TCR Based Therapy Market Size YoY (2018-2033) & (US$ Million)
Figure 35. China TCR Based Therapy Market Share by Type (2018-2033)
Figure 36. China TCR Based Therapy Market Share by Application (2018-2033)
Figure 37. Asia TCR Based Therapy Market Size YoY (2018-2033) & (US$ Million)
Figure 38. Asia TCR Based Therapy Market Share by Type (2018-2033)
Figure 39. Asia TCR Based Therapy Market Share by Application (2018-2033)
Figure 40. Asia TCR Based Therapy Market Share by Region (2018-2033)
Figure 41. Japan TCR Based Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. South Korea TCR Based Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. China Taiwan TCR Based Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Southeast Asia TCR Based Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. India TCR Based Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Australia TCR Based Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America TCR Based Therapy Market Size YoY (2018-2033) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America TCR Based Therapy Market Share by Type (2018-2033)
Figure 49. Middle East, Africa, and Latin America TCR Based Therapy Market Share by Application (2018-2033)
Figure 50. Middle East, Africa, and Latin America TCR Based Therapy Market Share by Country (2018-2033)
Figure 51. Brazil TCR Based Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 52. Mexico TCR Based Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 53. Turkey TCR Based Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 54. Saudi Arabia TCR Based Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 55. Israel TCR Based Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 56. GCC Countries TCR Based Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 57. Adaptimmune Therapeutics Revenue Growth Rate in TCR Based Therapy Business (2018-2023)
Figure 58. Alaunos Therapeutics Revenue Growth Rate in TCR Based Therapy Business (2018-2023)
Figure 59. Bristol Myers Squibb Revenue Growth Rate in TCR Based Therapy Business (2018-2023)
Figure 60. Cellular Biomedicine Revenue Growth Rate in TCR Based Therapy Business (2018-2023)
Figure 61. Gilead Biosciences Revenue Growth Rate in TCR Based Therapy Business (2018-2023)
Figure 62. GlaxoSmithKline Revenue Growth Rate in TCR Based Therapy Business (2018-2023)
Figure 63. Immatics Revenue Growth Rate in TCR Based Therapy Business (2018-2023)
Figure 64. Immunocore Revenue Growth Rate in TCR Based Therapy Business (2018-2023)
Figure 65. Lion TCR Revenue Growth Rate in TCR Based Therapy Business (2018-2023)
Figure 66. Takara Bio Revenue Growth Rate in TCR Based Therapy Business (2018-2023)
Figure 67. Zelluna Immunotherapy Revenue Growth Rate in TCR Based Therapy Business (2018-2023)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries